KAREN KIRWAN: Open Payments
NPI 1588668933 · FOREST GROVE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 20 payments from 12 companies in 2025. Trend: 2023 $177 · 2024 $125 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Corcept Therapeutics | 2 | $40 |
| ABBVIE INC. | 1 | $26 |
| PFIZER INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Ozempic, Korlym, AIRSUPRA, VRAYLAR, SHINGRIX, BEXSERO, ELIQUIS, BREZTRI.
Industry payments across OR — which companies pay providers there.
